60
Human Metabolome Technologies, Inc.
6090.T · JPX
¥605.00 -0.98% (-¥6.00)
1M +1.33%
Market Cap ¥3.40B
P/E Ratio 16.97x
Div. Yield 2.95%
ROE 11.12%
Bulios Fair Price
¥904.84
49.6% upside
Current Price
¥605
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6090.T is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
85 /100
Cheap P/B 1.86x
P/S 2.39x
P/E 16.97x
Growth
17 /100
Declining Book val. growth 1.05%
FCF growth 4.05%
EPS growth 9.63%
Profitability
57 /100
Moderate FCF margin 0.00%
Op. margin 14.76%
Gross margin 61.08%
Quality
56 /100
Average Asset turnover 0.62x
ROA 8.79%
ROIC 9.62%
Debt
100 /100
Low Net debt/EBITDA -3.94x
Int. coverage 115.56x
Debt/Equity 0.06x
Stability
84 /100
Stable Profitable years 6
EPS volatility 13.07%
Beta 1.50x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6090.T
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yasuhiro Ohata
Employees
62
Headquarters
Tsuruoka
Upcoming events
06 NOV
Earnings
Upcoming earnings report
29 JUN
Ex-Dividend
Ex-dividend date
29 JUN
Dividend Payment
Payment date